Zhejiang Tianyu Pharmaceutical Co., Ltd.

Shenzhen Stock Exchange 300702.SZ

Zhejiang Tianyu Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2023: USD 361.03 M

Zhejiang Tianyu Pharmaceutical Co., Ltd. Current Liabilities is USD 361.03 M for the year ending December 31, 2023, a -6.69% change year over year. Current liabilities are obligations that are expected to be settled within one year, including accounts payable, short-term debt, and other current liabilities.

Zhejiang Tianyu Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2022 was USD 386.91 M, a 30.95% change year over year.
Zhejiang Tianyu Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2021 was USD 295.47 M, a 56.84% change year over year.
Zhejiang Tianyu Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2020 was USD 188.39 M, a 77.94% change year over year.
Zhejiang Tianyu Pharmaceutical Co., Ltd. Current Liabilities for the year ending December 31, 2019 was USD 105.88 M, a -35.01% change year over year.

Key data

Date	Current Liabilities	Total Non-Current Liabilities	Shareholders' Equity	Long-Term Debt

Shenzhen Stock Exchange: 300702.SZ

Zhejiang Tianyu Pharmaceutical Co., Ltd.

CEO	Mr. Yong Jun Tu
IPO Date	Sept. 19, 2017
Location	China
Headquarters	Huangyan Jiangkou Chemical Dev Zn
Employees	4,690
Sector	Health Care
Industries Pharmaceuticals Chemicals & Advanced Materials

Description

Zhejiang Tianyu Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical intermediates and APIs in China and internationally. The company offers pharmaceutical intermediates and APIs of cardiovascular, anti-diabetic, anti-atherosclerosis, anticoagulant, and anti-asthmatic series. It also provides fine chemicals and CMO services. The company was founded in 1993 and is based in Taizhou, China.

Key trends

Past 5 years